AstraZeneca and Sachi are collaborating on trials for Non-Small Cell Lung Cancer (NSCLC), with the results of the Saffron trial potentially leading to U.S. approval.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca and Sachi are collaborating on trials for Non-Small Cell Lung Cancer (NSCLC), with the results of the Saffron trial potentially leading to U.S. approval.
Who's involved
What this event is mainly aboutAstraZenecaSachi
Keep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company